Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data

References

• Prostate C. NCCN clinical practice guidelines in oncology. JNCCN. 2018;Version 4.2018;1–124.
   Google Scholar
• Leitlinienprogramm Onkologie der AWMW DKeVu, e.V DK. Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. German S3-Guideline. 2016; Version 4.0 –Dezember 2016(www.leitlinienprogramm-onkologie.de): 1–352.
   Google Scholar
• Rasch C, Steenbakkers R, van Herk M. Target definition in prostate, head, and neck. Semin Radiat Oncol. 2005;15:136–145.
   PubMed Web of Science ®Google Scholar
• Chen L, Price RA, Jr., Wang L, et al. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys. 2004;60:636–647.
   PubMed Web of Science ®Google Scholar
• Seppala T, Visapaa H, Collan J, et al. Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: a comparison between two modalities. Strahlenther Onkol. 2015;191:862–868.
   PubMed Web of Science ®Google Scholar
• Muller BG, van den Bos W, Brausi M, et al. Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project. BJU Int. 2014;114:698–707.
   PubMed Web of Science ®Google Scholar
• Paterson C, Allwood-Spiers S, McCrea I, et al. Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: the MeRInO study. ctRO. 2017;2:13–18.
   Google Scholar
• Thorwarth D, Notohamiprodjo M, Zips D, et al. Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: a feasibility study. Z Med Phys. 2017;27:21–30.
   PubMed Web of Science ®Google Scholar
• Huang E, Dong L, Chandra A, et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53:261–268.
   PubMed Web of Science ®Google Scholar
• Casares-Magaz O, Moiseenko V, Hopper A, et al. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer. Acta Oncol. 2017;56:884–890.
   PubMed Web of Science ®Google Scholar
• Wust P, Joswig M, Graf R, et al. Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy: comparison of gold marker-based registrations with native MVCT. Strahlenther Onkol. 2017;193:700–706.
   Web of Science ®Google Scholar
• Tanaka O, Komeda H, Iida T, et al. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images. Radiol Med. 2017;122:204–207.
   PubMed Web of Science ®Google Scholar
• Choong ES, Hruby G, Yang J, et al. 78Gy with fiducial marker image-guided radiotherapy in prostate cancer: single center analysis of 301 patients. Asia Pac J Clin Oncol. 2017;13:e356–e363.
   PubMed Web of Science ®Google Scholar
• Walker A, Liney G, Metcalfe P, et al. MRI distortion: considerations for MRI based radiotherapy treatment planning. Australas Phys Eng Sci Med. 2014;37:103–113.
   PubMed Web of Science ®Google Scholar
• Foltz WD, Porter DA, Simeonov A, et al. Readout-segmented echo-planar diffusion-weighted imaging improves geometric performance for image-guided radiation therapy of pelvic tumors. Radiother Oncol. 2015;117:525–531.
   PubMed Web of Science ®Google Scholar
• Ciardo DJ-FB, Petralia G, Giorgia T, et al. Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments. submitted, not yet published. 2017. British Institute of Radiology.
   Google Scholar
• Gurney-Champion OJ, Lens E, van der Horst A, et al. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. Med Phys. 2015;42:2638–2647.
   PubMed Web of Science ®Google Scholar
• Tenhunen M, Korhonen J, Kapanen M, et al. MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience. Acta Oncol. 2018;28:1–6.
   Google Scholar
• Bossart EL, Stoyanova R, Sandler K, et al. Feasibility and initial dosimetric findings for a randomized trial using dose-painted multiparametric magnetic resonance imaging-defined targets in prostate cancer. Int J Radiat Oncol Biol Phys. 2016;95:827–834.
   PubMed Web of Science ®Google Scholar
• Maspero M, van den Berg CAT, Zijlstra F, et al. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy. Phys Med Biol. 2017;62:7981–8002.
   PubMed Web of Science ®Google Scholar
• Hamdan I, Bert J, Rest CCL, et al. Fully automatic deformable registration of pretreatment MRI/CT for image-guided prostate radiotherapy planning. Med Phys. 2017;44:6447–6455.
   PubMed Web of Science ®Google Scholar
• Huang K, Cao Y, Baharom U, et al. Phantom-based characterization of distortion on a magnetic resonance imaging simulator for radiation oncology. Phys Med Biol. 2016;61:774–790.
   PubMed Web of Science ®Google Scholar
• Rudat V, Nour A, Hammoud M, et al. Image-guided intensity-modulated radiotherapy of prostate cancer: analysis of interfractional errors and acute toxicity. Strahlenther Onkol. 2016;192:109–117.
   PubMed Web of Science ®Google Scholar
• Engels B, Soete G, Gevaert T, et al. Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer. Radiother Oncol. 2014;111:106–109.
   PubMed Web of Science ®Google Scholar
• Ballhausen H, Li M, Hegemann NS, et al. Intra-fraction motion of the prostate is a random walk. Phys Med Biol. 2015;60:549–563.
   PubMed Web of Science ®Google Scholar
• Willoughby TR, Kupelian PA, Pouliot J, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65:528–534.
   PubMed Web of Science ®Google Scholar
• Eckert F, Alloussi S, Paulsen F, et al. Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer. BMC Cancer. 2013;13:27.
   PubMed Web of Science ®Google Scholar
• Muller AC, Mischinger J, Klotz T, et al. Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients. Radiol Oncol. 2016;50:329–336.
   PubMed Web of Science ®Google Scholar